Israel Active

Former Member of Knesset Michael (Miki) Eitan (aged 77) was once completely debilitated by Parkinson’s disease. In Feb 2021, he underwent Deep Brain Stimulation (DBS) at Hadassah Ein Kerem in Jerusalem. Now, although the disease continues, most of his symptoms have gone.

Alverno Laboratories, one of the largest integrated laboratory networks in the United States, is to deploy the Galen AI platform from Israel’s Ibex Medical Analytics (see previously) to help pathologists provide accurate cancer diagnosis for patients.

Ben Gurion University has established a new rehabilitation lab for stroke victims. It is based at ADI ALEH Negev Nahalat Eran Rehabilitation Village in southern Israel (see previously). Patients spend 3 - 5 hours per day with cutting-edge equipment that utilizes the brain’s plasticity to repair itself.

Join Technion UK’s webinar on 24th Aug at 2pm UK time. Professor Alon Wolf, Head of Robotics and Vice President of Israel’s Technion Institute, will talk about his work. His startup Medrobotics is now transforming his search & rescue robotic snake into an anatomical surgery tool.

Israel’s CartiHeal (see previously) has just announced successful results in the two-year trial of its Agili-C implant for 251 patients with damaged knee cartilage. Over 77% of patients said their condition had improved, compared to 33% of those who had conventional treatment.

Israel’s ZygoFix (see previously) has obtained the European CE mark for its minimally invasive screwless zLOCK Spinal Fusion system for the treatment of chronic back pain. The system has been in clinical use for over three years in Hungary and Israel.

Israel’s Newpace has developed. the Implantable Subcutaneous String-cardio Defibrillator (ISSD) - a low-invasive heart rhythm defibrillator that is implanted under the skin and is recharged and monitored wirelessly using Bluetooth. Newpace is now to use the battery system from Israel’s Powermat.

In a global first, doctors at Israel’s Rambam Medical Center in Haifa performed cryotherapy to treat superficial bladder cancer in a 60-year-old patient. The technology was developed by Israel’s Vessi Medical (see previously). Bladder cancer is the most common cancer in men over 50.

Israel’s Health Ministry has approved a Phase 2 trial of Covid-19 treatment MesenCure (see previously) from Israel’s Bonus BioGroup. The treatment helped 15 out of 17 severe Covid cases, to be released from hospital just one day after receiving their final dose.

Tel Aviv’s Sourasky (Ichilov) is the first hospital to use ultra-violet (UV) light to disinfect medical spaces. The J. Protect system, from Israel’s Juganu (see ) uses UV-A in occupied rooms and UV-C when the room is empty. Bacteria, fungi and viruses (e.g., Covid-19) are killed in one hour.